Reuters: Health
A development program for an atopic dermatitis treatment has failed, German biotech Morphosys said, sending its shares down 9% in early Frankfurt trade on Tuesday.
Morphosys ends development of dermatitis treatment, shares fall
Morphosys ends development of dermatitis treatment, shares fall
Reuters: Health
A development program for an atopic dermatitis treatment has failed, German biotech Morphosys said, sending its shares down 9% in early Frankfurt trade on Tuesday.
Reuters: Health
A development program for an atopic dermatitis treatment has failed, German biotech Morphosys said, sending its shares down 9% in early Frankfurt trade on Tuesday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment